(Q30336409)

19 June 2017

1 reference

title

Safety issues in cell-based intervention trials. (English)

1 reference

19 June 2017

15

1 reference

19 June 2017

Alison S. Bateman-House

object named as

Alison S Bateman-House

2

0 references

Davor Solter

object named as

Davor Solter

13

0 references

Ruth Faden

18

object named as

Ruth R Faden

1 reference

19 June 2017

10

David H Sachs

1 reference

19 June 2017

17

John D Gearhart

1 reference

19 June 2017

Liza Dawson

1

1 reference

19 June 2017

Dawn Mueller Agnew

3

1 reference

19 June 2017

Hilary Bok

4

1 reference

19 June 2017

Dan W Brock

5

1 reference

19 June 2017

Aravinda Chakravarti

6

1 reference

19 June 2017

Mark Greene

7

1 reference

19 June 2017

Patricia A King

8

1 reference

19 June 2017

Stephen J O'Brien

9

1 reference

19 June 2017

Kathryn E Schill

11

1 reference

19 June 2017

Andrew Siegel

12

1 reference

19 June 2017

Sonia M Suter

14

1 reference

19 June 2017

LeRoy B Walters

16

1 reference

19 June 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

19 June 2017

published in

Fertility and Sterility

1 reference

19 June 2017

volume

80

1 reference

19 June 2017

issue

5

1 reference

19 June 2017

page(s)

1077-1085

1 reference

Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells

19 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Feeder-free growth of undifferentiated human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Feeding hungry stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Call for moratorium on xenotransplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Uncertainty in xenotransplantation: individual benefit versus collective risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

A Tragic Compromise on Stem Cell Derivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand-- a fail-safe protection against cellular misbehavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Gene therapy for SCID--a complication after remarkable progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Stem Cells Step Closer to the Clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Cell fusion is the principal source of bone-marrow-derived hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Transplanted bone marrow regenerates liver by cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Bilateral human fetal striatal transplantation in Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Immune parameters affecting adenoviral vector gene therapy in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Immune regulation within the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Policy developments in regulatory approval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

The prognosis of prognostic factors in phase I clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Second cancer case halts gene-therapy trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Gene therapy. RAC hears a plea for resuming trials, despite cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

Gene therapy in the post-Gelsinger era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2902218-0

10.1016/S0015-0282(03)02218-0

7 January 2021

Identifiers

DOI

1 reference

19 June 2017

1 reference